These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 6894859)

  • 1. Resistance to androgen in murine lymphosarcoma lines resistant or sensitive to glucocorticoid hormone.
    Sasson S; Mayer M
    Br J Cancer; 1981 Jul; 44(1):127-8. PubMed ID: 6894859
    [No Abstract]   [Full Text] [Related]  

  • 2. Effect of glucocorticoid hormones in vitro on the structural integrity of nuclei in corticosteroid-sensitive and -resistant lines of lymphosarcoma P1798.
    Nicholson ML; Young DA
    Cancer Res; 1978 Nov; 38(11 Pt 1):3673-80. PubMed ID: 581273
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Drug sensitivity and some characteristics of a bleomycin-resistant subline of mouse lymphoblastoma L5178Y cells.
    Suzuki H; Nishimura T; Tanaka N
    J Antibiot (Tokyo); 1981 Sep; 34(9):1210-2. PubMed ID: 6173370
    [No Abstract]   [Full Text] [Related]  

  • 4. Glucocorticoid binding properties of mouse thymic lymphosarcoma cell populations selected for resistance to the cytolytic effects of glucocorticoids in vivo.
    Chan AK; Thompson EA
    J Natl Cancer Inst; 1983 Sep; 71(3):579-82. PubMed ID: 6577232
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Isolation and characterization of cortisol-sensitive and -resistant P1798 mouse lymphosarcoma cell lines.
    Chi CW; Sykes D; Ip MM
    Mol Cell Endocrinol; 1989 Apr; 62(2):167-76. PubMed ID: 2744225
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Apoptosis-inducing and anti-tumor effect of cyclophosphamide, cisplatin and adriamycin used separately or combined in murine lymphosarcoma LS].
    Nikolin VP; Kaledin VI; Baĭmak TIu; Galiamova MR; Popova NA; Voĭtsitskiĭ VE
    Vopr Onkol; 2002; 48(2):211-5. PubMed ID: 12227071
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Isolation and characterization of lymphosarcoma P1798 variants selected for resistance to the cytolytic effects of glucocorticoids in vivo and in culture.
    Wood KM; Thompson EA
    Mol Cell Endocrinol; 1984 Sep; 37(2):169-80. PubMed ID: 6092172
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Combined use of rubomycin and olivomycin in treatment of murine lymphosarcoma].
    Shopin VA; Kriatova GN
    Antibiotiki; 1972 Apr; 17(4):325-9. PubMed ID: 5068419
    [No Abstract]   [Full Text] [Related]  

  • 9. Animal model of drug-resistant tumor progression.
    Mironova N; Shklyaeva O; Andreeva E; Popova N; Kaledin V; Nikolin V; Vlassov V; Zenkova M
    Ann N Y Acad Sci; 2006 Dec; 1091():490-500. PubMed ID: 17341638
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A study of thymic lymphosarcoma developing in magnesium-deficient rats.
    Bois P; Sandborn EB; Messier PE
    Cancer Res; 1969 Apr; 29(4):763-75. PubMed ID: 5251702
    [No Abstract]   [Full Text] [Related]  

  • 11. Resistance to 9-beta-D-arabinofuranosyladenine in murine tumor cells.
    LePage GA
    Cancer Res; 1978 Aug; 38(8):2314-6. PubMed ID: 580902
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Subfractionation of malignant variants of metastatic murine lymphosarcoma cells by countercurrent distribution in two-polymer aqueous phases.
    Miner KM; Walter H; Nicolson GL
    Biochemistry; 1981 Oct; 20(21):6244-50. PubMed ID: 6895470
    [No Abstract]   [Full Text] [Related]  

  • 13. Nonmutational alteration in glucocorticoid sensitivity of lymphosarcoma P1798.
    Davis JM; Chan AK; Thompson EA
    J Natl Cancer Inst; 1980 Jan; 64(1):55-62. PubMed ID: 6928047
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Combined therapy with 5-azacytidine and hydrocortisone in glucocorticoid-sensitive and -resistant mouse P1798 lymphosarcoma.
    Chi CW; Ip MM
    J Natl Cancer Inst; 1988 Aug; 80(12):912-8. PubMed ID: 2456400
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of the regional lymph nodes in the cure of a murine lymphosarcoma.
    Perez CA; Stewart CC; Palmer-Hanes LA; Powers WE
    Cancer; 1973 Sep; 32(3):562-72. PubMed ID: 4740814
    [No Abstract]   [Full Text] [Related]  

  • 16. Selection and in vivo properties of lectin-attachment variants of malignant murine lymphosarcoma cell lines.
    Reading CL; Belloni PN; Nicolson GL
    J Natl Cancer Inst; 1980 May; 64(5):1241-9. PubMed ID: 6929022
    [No Abstract]   [Full Text] [Related]  

  • 17. Tempol reduces the therapeutic effect of cyclophosphamide on an experimental tumour model.
    Kaledin VI; Popova NA; Nikolin VP; Vasilieva ED; Kirilyuk IA; Grigor'ev IA
    Free Radic Res; 2009 Jul; 43(7):685-90. PubMed ID: 19526393
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Effects of sodium diphosphate in lymphosarcoma in mice].
    Gericke D
    Experientia; 1971 Aug; 27(8):944. PubMed ID: 5172485
    [No Abstract]   [Full Text] [Related]  

  • 19. Kinetics of cell proliferation in a rapidly growing murine lymphosarcoma.
    Tribukait B; Veninga T; Lemstra V; Linder I; Sundius G
    Acta Radiol Oncol; 1981; 20(1):39-49. PubMed ID: 6264742
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [On the cellular reaction of the thymus following tumor implantation].
    Klug H
    Experientia; 1968 May; 24(5):461-2. PubMed ID: 5695500
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.